Why NR is used in studies more commonly than NMN | David Sinclair
The bulk of the research on NAD+ precursors has focused on nicotinamide riboside largely because it is inexpensive to produce. Nicotinamide mononucleotide, however, is a large, complex molecule that is difficult and, therefore, costly to produce. And, although these products are widely available on the common market in supplement form, Dr. Sinclair does not endorse them, preferring to focus his efforts on developing pharmaceutical-grade products. In this clip, Dr. David Sinclair discusses the economic issues associated with research using nicotinamide riboside and nicotinamide mononucleotide.
Member support keeps us strong.
If you enjoy the fruits of , you can participate in helping us to keep improving it. Creating a pay-what-you-can subscription does just that! Plus, we throw in occasional member perks and, more importantly, churn out the best possible content without concerning ourselves with the wishes of any dark overlords.
Our website is 100% supported by people like you through this pay-what-you-can mechanism.
Fundamentals$15 / month
Loyal Fan$25 / month
Super Fan$50 / month
Power Supporter$125 / month
Heroic Supporter$250 / month